ANTHONY NOLAN

Charity overview
Activities - how the charity spends its money
Anthony Nolan saves the lives of people with blood cancer. By growing our register of stem cell donors, conducting research and providing outstanding support to patients, Anthony Nolan cures people's blood cancer and blood disorders. But we need to do more. Without you, there is no cure.
Income and expenditure
Data for financial year ending 31 March 2024
Total income:
£62,987,000
Donations and legacies | £8.59m | |
Charitable activities | £54.00m | |
Other trading activities | £86.00k | |
Investments | £243.00k | |
Other | £72.00k |
Total expenditure:
£64,943,000
Raising funds | £4.18m | |
Charitable activities | £60.77m | |
Other | £0 |
£0 investments gains (losses)
Total income includes £333,000 from 1 government contract(s) and £144,000 from 2 government grant(s)
Charitable expenditure
Charitable expenditure with investment gains
Charitable expenditure
Some charities generate all, or a substantial part, of their income from investments which may have been donated to the charity as endowment or set aside by the charity from its own resources in the past. Such investments usually take the form of stocks and shares but may include other assets, such as property, that are capable of generating income and/or capital growth.
In managing their spending and investments charities need to strike a balance between the needs of future and current beneficiaries. They also need to take account of spending commitments that may stretch over a number of future years. To do this, charities will normally adopt an investment strategy designed to generate both income and capital growth. To maximise returns trustees may commit to investment strategies for several years.
Investments can experience large swings in value so trustees may, in a particular year, decide to realise and spend part of their charity’s capital or to invest part of its income.
By clicking the investment gains checkbox the charitable spending bar is adjusted to take account of capital growth as well as income. This shows the balance the charity is striking, between spending on current beneficiaries and retaining resources for future beneficiaries.
Raising funds and other expenditure | £4.18m | |
Charitable expenditure | £60.77m |
People

441 Employee(s)
9 Trustee(s)
1109 Volunteer(s)
Employees with total benefits over £60,000
Number of employees | |
---|---|
£60k to £70k | 22 |
£70k to £80k | 9 |
£80k to £90k | 6 |
£90k to £100k | 3 |
£100k to £110k | 3 |
£120k to £130k | 1 |
£130k to £140k | 1 |
£150k to £200k | 1 |
Fundraising
Trading
Trustee payments
What, who, how, where
- The Advancement Of Health Or Saving Of Lives
- Children/young People
- Elderly/old People
- People With Disabilities
- Provides Services
- Sponsors Or Undertakes Research
- Throughout England And Wales
- Northern Ireland
- Scotland
Governance
- ANTHONY NOLAN TRUST (Previous name)
- THE ANTHONY NOLAN BONE MARROW TRUST (Previous name)
- Bullying and harassment policy and procedures
- Campaigns and political activity policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Trustees
Trustees are the people responsible for controlling the work, management and administration of the charity on behalf of its beneficiaries. Generally trustees are treasurer, chair, board member etc. The trustees are responsible for keeping this list up to date and can do this by updating their details as they happen through the online service
9 Trustee(s)
Name | Role | Date of appointment | Other trusteeships | Reporting status of other trusteeships | ||||
---|---|---|---|---|---|---|---|---|
Nicola Karina Christina Horlick | Chair | 22 July 2021 |
|
|
||||
Dr Victoria Therese Potter | Trustee | 03 July 2023 |
|
|
||||
Katy Minshall | Trustee | 17 April 2023 |
|
|
||||
Deborah Clare Lee | Trustee | 09 November 2022 |
|
|
||||
Matthew James Barrington Miller | Trustee | 20 January 2022 |
|
|||||
Dr Susan Esther Conroy | Trustee | 20 January 2022 |
|
|
||||
Mark Ritson | Trustee | 24 January 2019 |
|
|
||||
Martin John Hallam Laws | Trustee | 27 March 2018 |
|
|
||||
MICHAEL ALTENDORF | Trustee | 14 July 2016 |
|
|
Financial history
Financial period end date
Income / Expenditure | 31/03/2020 | 31/03/2021 | 31/03/2022 | 31/03/2023 | 31/03/2024 | ||
---|---|---|---|---|---|---|---|
|
Total gross income | £55.39m | £51.38m | £53.54m | £58.59m | £62.99m | |
|
Total expenditure | £55.26m | £51.07m | £53.04m | £60.14m | £64.94m | |
|
Income from government contracts | £310.00k | £360.00k | £333.00k | £333.00k | £333.00k | |
|
Income from government grants | N/A | £315.00k | N/A | £333.00k | £144.00k | |
|
Income - Donations and legacies | £9.14m | £8.80m | £9.05m | £8.74m | £8.59m | |
|
Income - Other trading activities | £594.00k | £320.00k | £89.00k | £118.00k | £86.00k | |
|
Income - Charitable activities | £45.36m | £41.89m | £44.31m | £49.57m | £54.00m | |
|
Income - Endowments | £0 | £0 | £0 | £0 | £0 | |
|
Income - Investment | £194.00k | £102.00k | £89.00k | £154.00k | £243.00k | |
|
Income - Other | £106.00k | £261.00k | £11.00k | £8.00k | £72.00k | |
|
Income - Legacies | £645.00k | £694.00k | £821.00k | £709.00k | £871.00k | |
|
Expenditure - Charitable activities | £50.66m | £47.80m | £49.43m | £55.92m | £60.77m | |
|
Expenditure - Raising funds | £4.60m | £3.27m | £3.61m | £4.22m | £4.18m | |
|
Expenditure - Governance | £307.00k | £321.00k | £374.00k | £409.00k | £403.00k | |
|
Expenditure - Grants institution | £40.00k | £167.00k | £165.00k | £151.00k | £579.00k | |
|
Expenditure - Investment management | £0 | £10.21k | £0 | £0 | £0 | |
|
Expenditure - Other | £0 | £0 | £0 | £0 | £0 |
Assets and liabilities
Definitions for assets and liabilities
These are assets, other than investments, which are held for more than 12 months and used to run and administer the charity such as buildings, offices, exhibits and fixtures and fittings.
Long term InvestmentsInvestments are assets held by the charity with the sole aim of generating income which will be used for their charitable purposes such as deposit accounts, shares, rental property and unit trusts.
Investment assets are re-valued every year and included in the balance sheet at their current market value.
Long term investments are held for more than 12 months.
These are assets held generally for less than 12 months such as cash and bank balances, debtors, investments to be sold within the coming year and trading stock.
Defined benefit pension scheme asset or liabilityThis is a surplus or deficit in any defined benefit pension scheme operated and represents a potential long-term asset or liability.
Total liabilitiesThese are all the amounts owed by the charity at the balance sheet date to third parties such as bills due but not yet paid, bank overdrafts and loans and mortgages.
Asset / Liability | 31/03/2020 | 31/03/2021 | 31/03/2022 | 31/03/2023 | 31/03/2024 | ||
---|---|---|---|---|---|---|---|
|
Own use assets | £2.47m | £3.00m | £4.01m | £3.74m | £3.07m | |
|
Long-term investments | £2.91m | £100.00k | £0 | £0 | £0 | |
|
Other assets | £19.96m | £21.85m | £20.78m | £19.84m | £18.52m | |
|
Defined benefit pension scheme asset or liability | £0 | £0 | £0 | £0 | £0 | |
|
Total liabilities | £11.02m | £10.05m | £9.39m | £9.73m | £9.69m |
Accounts and annual returns
Title | Reporting year | Date received | Received | Download |
---|---|---|---|---|
Annual return | 31 March 2024 | 03 September 2024 | On Time | |
Accounts and TAR | 31 March 2024 | 03 September 2024 | On Time | Download Open in new window |
Annual return | 31 March 2023 | 24 October 2023 | On Time | |
Accounts and TAR | 31 March 2023 | 24 October 2023 | On Time | Download Open in new window |
Annual return | 31 March 2022 | 31 August 2022 | On Time | |
Accounts and TAR | 31 March 2022 | 31 August 2022 | On Time | Download Open in new window |
Annual return | 31 March 2021 | 16 December 2021 | On Time | |
Accounts and TAR | 31 March 2021 | 16 December 2021 | On Time | Download Open in new window |
Annual return | 31 March 2020 | 07 August 2020 | On Time | |
Accounts and TAR | 31 March 2020 | 07 August 2020 | On Time | Download Open in new window |
Governing document
It is not the full text of the charity's governing document.
MEMORANDUM AND ARTICLES INCORPORATED 03 MAY 1989 AS AMENDED BY SPECIAL RESOLUTION(S) DATED 19 FEB 1990 AS AMENDED BY SPECIAL RESOLUTION(S) DATED 25 MAY 1990 AS AMENDED BY SPECIAL RESOLUTION(S) DATED 06 APR 2004 AS AMENDED BY SPECIAL RESOLUTION(S) DATED 21 JUN 2007 AS AMENDED BY CERTIFICATE OF INCORPORATION ON CHANGE OF NAME DATED 18 FEB 2013 AS AMENDED BY SPECIAL RESOLUTION(S) DATED 06 APR 2017 AS AMENDED BY SPECIAL RESOLUTION REGISTERED AT COMPANIES HOUSE ON 24 APR 2017 as amended on 24 Jan 2022
Charitable objects
THE OBJECTS FOR WHICH THE COMPANY IS ESTABLISHED ARE: 2.1 THE RELIEF, TREATMENT, CURE OR SUPPORT OF THOSE WITH BLOOD CANCERS OR OTHER BLOOD DISORDERS OR AFFECTED BY AN IMMUNOLOGICAL DEFICIENCY AND ANY SIMILAR OR RELATED DISEASES OR CONDITIONS (INCLUDING THE PROVISION OF SUPPORT TO THEIR FAMILY MEMBERS OR CARERS); 2.2 THE RELIEF, TREATMENT, CURE OR SUPPORT OF THOSE WHO REQUIRE A STEM CELL TRANSPLANT OR WHO ARE AFFECTED BY ANY DISEASE OR CONDITION THAT MAY BE RELIEVED, TREATED OR CURED BY ANY ORGAN OR STEM CELL TRANSPLANT (INCLUDING THE PROVISION OF SUPPORT TO THEIR FAMILY MEMBERS OR CARERS); 2.3 THE ADVANCEMENT OF RESEARCH INTO THE CAUSES OF AND THE DIAGNOSIS, RELIEF, TREATMENT OR CURE OF THOSE REQUIRING A STEM CELL TRANSPLANT OR WHO ARE AFFECTED BY AN IMMUNOLOGICAL DEFICIENCY OR ANY SIMILAR OR RELATED DISEASES OR CONDITIONS AND TO PUBLISH THE USEFUL RESULTS OF SUCH RESEARCH; AND 2.4 THE ADVANCEMENT OF RESEARCH INTO IMPROVING ORGAN OR STEM CELL CURRENT NEW TRANSPLANTATION OR ANY RELATED TECHNIQUE OR TECHNOLOGY AND TO PUBLISH THE USEFUL RESULTS OF SUCH RESEARCH.
Area of benefit
NOT DEFINED
Contact information
- Address:
-
Anthony Nolan
2-3 Heathgate Place
LONDON
NW3 2NU
- Phone:
- 0303 303 0303
- Email:
- info@anthonynolan.org
Tell us whether you accept cookies
We use cookies to collect information about how you use your Charity Commission Account, such as pages you visit.
We use this information to better understand how you use our website so that we can improve your user experience and present more relevant content.
Thank you for your feedback. Do you have 5 minutes to tell us what you think of this service?Open in new window